Navigating immunosuppression in a pandemic: A guide for the dermatologist from the COVID Task Force of the Medical Dermatology Society and Society of Dermatology Hospitalists

Dermatologists treating immune-mediated skin disease must now contend with the uncertainties associated with immunosuppressive use in the context of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic. Although the risk of infection with many commonly used immunosuppressive age...

Descripción completa

Detalles Bibliográficos
Autores principales: Zahedi Niaki, Omid, Anadkat, Milan J., Chen, Steven T., Fox, Lindy P., Harp, Joanna, Micheletti, Robert G., Nambudiri, Vinod E., Pasieka, Helena B., Shinohara, Michi M., Rosenbach, Misha, Merola, Joseph F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: by the American Academy of Dermatology, Inc. 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7303642/
https://www.ncbi.nlm.nih.gov/pubmed/32569797
http://dx.doi.org/10.1016/j.jaad.2020.06.051

Ejemplares similares

Ejemplares similares